| Liraglutide and cardiovascular outcomes in type 2 diabetes SP Marso, GH Daniels, K Brown-Frandsen, P Kristensen, JFE Mann, ... New England Journal of Medicine 375 (4), 311-322, 2016 | 7003 | 2016 |
| Liraglutide and renal outcomes in type 2 diabetes JFE Mann, DD Ørsted, K Brown-Frandsen, SP Marso, NR Poulter, ... New England Journal of Medicine 377 (9), 839-848, 2017 | 1178 | 2017 |
| Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials N Chaturvedi, M Porta, R Klein, T Orchard, J Fuller, HH Parving, R Bilous, ... The Lancet 372 (9647), 1394-1402, 2008 | 539 | 2008 |
| Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial AK Sjølie, R Klein, M Porta, T Orchard, J Fuller, HH Parving, R Bilous, ... The Lancet 372 (9647), 1385-1393, 2008 | 532 | 2008 |
| Semaglutide and cardiovascular outcomes in obesity without diabetes AM Lincoff, K Brown-Frandsen, HM Colhoun, J Deanfield, SS Emerson, ... New England Journal of Medicine 389 (24), 2221-2232, 2023 | 227 | 2023 |
| Increased thyroid cancer risk in acromegaly S Dagdelen, N Cinar, T Erbas Pituitary 17, 299-306, 2014 | 94 | 2014 |
| Metabolik sendrom klavuzu M Arslan, A Atmaca, G Ayvaz, N Başkal, Z Beyhan, E Bolu, S Can, ... Türkiye endokrinoloji ve metabolizma derneği, 7-13, 2009 | 94 | 2009 |
| Influence of type 2 diabetes mellitus on bone mineral density response to bisphosphonates in late postmenopausal osteoporosis S Dagdelen, D Sener, M Bayraktar Advances in Therapy 24, 1314-1320, 2007 | 69 | 2007 |
| Evaluation of thyroid diseases and differentiated thyroid cancer in acromegalic patients S Dogan, A Atmaca, S Dagdelen, B Erbas, T Erbas Endocrine 45, 114-121, 2014 | 62 | 2014 |
| Follow-up of pregnancy in acromegalic women: different presentations and outcomes A Atmaca, S Dagdelen, T Erbas Experimental and clinical endocrinology & diabetes 114 (03), 135-139, 2006 | 58 | 2006 |
| Endocrine involvement in systemic amyloidosis D Ozdemir, S Dagdelen, T Erbas Endocrine Practice 16 (6), 1056-1063, 2010 | 54 | 2010 |
| Peroxisome proliferator-activated receptor-γ: novel therapeutic target linking adiposity, insulin resistance, and atherosclerosis A Kepez, A Oto, S Dagdelen BioDrugs 20, 121-135, 2006 | 45 | 2006 |
| Clinical characteristics and outcomes of COVID‐19 in patients with type 2 diabetes in Turkey: A nationwide study (TurCoviDia) A Sonmez, I Demirci, C Haymana, I Tasci, S Dagdelen, S Salman, N Ata, ... Journal of diabetes 13 (7), 585-595, 2021 | 43 | 2021 |
| Management of patients with diabetes and obesity in the COVID-19 era: Experiences and learnings from South and East Europe, the Middle East, and Africa F Giorgino, S Bhana, L Czupryniak, S Dagdelen, GR Galstyan, A Janež, ... diabetes research and clinical practice 172, 108617, 2021 | 43 | 2021 |
| Exposure to candesartan during the first trimester of pregnancy in type 1 diabetes: experience from the placebo-controlled DIabetic REtinopathy Candesartan Trials M Porta, JW Hainer, SO Jansson, A Malm, R Bilous, N Chaturvedi, ... Diabetologia 54, 1298-1303, 2011 | 39 | 2011 |
| Volatile Composition, Antioxidant and Antimicrobial Activities of Herbal Plants Used in the Manufacture of V an Herby (OTLU) Cheese S Dagdelen, T Bilenler, G Durmaz, I Gokbulut, AA Hayaloglu, I Karabulut Journal of Food Processing and Preservation 38 (4), 1716-1725, 2014 | 33 | 2014 |
| Assessment of cardiac autonomic functions by heart rate recovery, heart rate variability and QT dynamicity parameters in patients with acromegaly M Dural, G Kabakcı, N Çınar, T Erbaş, U Canpolat, KM Gürses, ... Pituitary 17, 163-170, 2014 | 32 | 2014 |
| Cavernous sinus invasion might be a risk factor for apoplexy N Cinar, Y Tekinel, S Dagdelen, H Oruckaptan, F Soylemezoglu, T Erbas Pituitary 16, 483-489, 2013 | 31 | 2013 |
| Thrombin-activatable fibrinolysis inhibitor activity and global fibrinolytic capacity in Type 1 diabetes: evidence for normal fibrinolytic state A Harmanci, N Kandemir, S Dagdelen, N Gonc, Y Buyukasik, ... Journal of Diabetes and its Complications 20 (1), 40-44, 2006 | 28 | 2006 |
| Unexpectedly lower mortality rates in COVID-19 patients with and without type 2 diabetes in Istanbul I Satman, I Demirci, C Haymana, I Tasci, S Salman, N Ata, S Dagdelen, ... diabetes research and clinical practice 174, 108753, 2021 | 24 | 2021 |
